Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 HR+/HER2- Early Breast Cancer 1 HR+/HER2+ Early Breast Cancer 1 Endometrial Stromal Tumors 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 25 Paclitaxel 20 Carboplatin 17 Bevacizumab 12 Specimen Handling 10 Letrozole 10 abemaciclib 7 dostarlimab 6 Taxes 6 Blood Specimen Collection 6 Medroxyprogesterone Acetate 5 Magnetic Resonance Spectroscopy 5 Fulvestrant 5 Drug Therapy 5 Doxorubicin 5 Cisplatin 5 Biopsy 5 olaparib 4 lenvatinib 4 atezolizumab 4 Radiotherapy 4 Progestins 4 Observation 4 Nivolumab 4 Megestrol Acetate 4 Immunoglobulin G 4 Gemcitabine 4 trastuzumab deruxtecan 3 palbociclib 3 X-Rays 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Aromatase Inhibitors × Clear all

NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡